Developing a chewing gum to reduce the incidence of Covid-19
A chewing gum impregnated with a plant-grown protein can serve as a “trap” for the SARS-CoV-2 virus, reducing viral load in the chewers saliva and potentially tamping down transmission.
Choosing the University of Pennsylvania for Its Excellence: As a Student, a Patient, and Employee
Carter Caldwell, the Director of the Penn Medicine Co-Investment Program, wrote a guest blog for Penn Medicine News on how the University has impacted his life as a student, a patient, and an employee
Applications now being accepted for the President’s Innovation Prize
Unique to both Penn and across higher education, the Prize underscores the University’s considerable commitment to encouraging students to put their knowledge to work for the betterment of humankind.
Science to Suits Podcast
The Penn Biotech Healthcare Consulting Group has a podcast called "Science to Suits" focused on healthcare and biotech commercialization.
This tech startup is helping N. Philadelphians take control of their health
The founder, Deboleena (Deb) Dutta graduated from Wharton and participated in the PCI I-Corps program with Viora Health.
$10 Million gift establishes new Colton Center for Autoimmunity at Penn Medicine
Center brings together autoimmune disease researchers and clinicians to advance diagnosis and treatment
I-Corps graduate, Strella Biotechnology, featured in Washington Post story
A featured story on Katherine Sizov, founder of Strella Biotechnology, and how the company's sensors are reducing food waste and fighting climate change.
Penn launches $750M investment in science, engineering, and medicine
President Amy Gutmann has announced the launch of a $750 million investment.
After setbacks, cell therapy for glioblastoma moves onto new chapter
At Penn, a leader in GBM cellular therapies since the early days of this technology, a new CAR cell therapy could find its way into clinical trials by next year in collaboration with Tmunity.
Scout Bio raises $4.75M to advance gene therapy for pets
The company has now raised more than $35 million since its inception.